Literature DB >> 22244658

The epidemiology of endometrial and ovarian cancer.

Daniel W Cramer1.   

Abstract

This review highlights similarities in the epidemiology of endometrial and ovarian cancer, including highly correlated incidence rates and similar risk factor profiles. Factors that decrease risk for both cancers include a late menarche, early age at first birth, giving birth and breastfeeding, and use of oral contraceptives. Short or irregular cycles and late menopause are associated with increased risk for both. Other risk factors that appear to operate in a similar direction include decreased risk associated with IUD use or a tubal ligation, and increased risk associated with obesity, lack of exercise, and use of talc powders in genital hygiene. Estrogen excess is proposed as the underlying mechanism for most endometrial cancers, whereas incessant ovulation has been suggested as the explanation for ovarian cancer. However, an increased number of estimated ovulatory cycles correlates directly with risk for both endometrial and ovarian cancer, suggesting that reproductive tissue turnover with an accumulation of PTEN or p53 mutations represents a possible common mechanism. An immune-based explanation involving mucin proteins represents another common mechanism that could explain additional risk factors. Maintenance of ideal weight, breastfeeding children, use of oral contraceptives, and avoidance of talc powders in genital hygiene are measures that could lower the risk for both types of cancer. Careful selection of patients for prophylactic oophorectomy for those women who are coming to hysterectomy for benign disease is an additional measure to consider for ovarian cancer.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22244658      PMCID: PMC3259524          DOI: 10.1016/j.hoc.2011.10.009

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  75 in total

1.  Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women.

Authors:  C Rodriguez; A V Patel; E E Calle; E J Jacob; M J Thun
Journal:  JAMA       Date:  2001-03-21       Impact factor: 56.272

2.  Reproductive, menstrual, and medical risk factors for endometrial cancer: results from a case-control study.

Authors:  L A Brinton; M L Berman; R Mortel; L B Twiggs; R J Barrett; G D Wilbanks; L Lannom; R N Hoover
Journal:  Am J Obstet Gynecol       Date:  1992-11       Impact factor: 8.661

3.  Lactation and risk of endometrial cancer in Japan: a case-control study.

Authors:  Chikako Okamura; Yoshitaka Tsubono; Kiyoshi Ito; Hitoshi Niikura; Tadao Takano; Satoru Nagase; Kohsuke Yoshinaga; Yukihiro Terada; Takashi Murakami; Shinji Sato; Daisuke Aoki; Toshiko Jobo; Kunihiro Okamura; Nobuo Yaegashi
Journal:  Tohoku J Exp Med       Date:  2006-02       Impact factor: 1.848

4.  Impact of hysterectomy and bilateral oophorectomy on race-specific rates of corpus, cervical, and ovarian cancers in the United States.

Authors:  Ray M Merrill
Journal:  Ann Epidemiol       Date:  2006-10-04       Impact factor: 3.797

5.  Perineal use of talcum powder and endometrial cancer risk.

Authors:  Stalo Karageorgi; Margaret A Gates; Susan E Hankinson; Immaculata De Vivo
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-04-20       Impact factor: 4.254

Review 6.  Does smoking increase risk of ovarian cancer? A systematic review.

Authors:  Susan J Jordan; David C Whiteman; David M Purdie; Adèle C Green; Penelope M Webb
Journal:  Gynecol Oncol       Date:  2006-09-26       Impact factor: 5.482

7.  Assessing ovarian cancer risk when considering elective oophorectomy at the time of hysterectomy.

Authors:  Allison F Vitonis; Linda Titus-Ernstoff; Daniel W Cramer
Journal:  Obstet Gynecol       Date:  2011-05       Impact factor: 7.661

8.  Infertility-associated endometrial cancer risk may be limited to specific subgroups of infertile women.

Authors:  L G Escobedo; N C Lee; H B Peterson; P A Wingo
Journal:  Obstet Gynecol       Date:  1991-01       Impact factor: 7.661

9.  Reduced risk of breast and endometrial cancer among women with hip fractures (Sweden).

Authors:  I Persson; H O Adami; J K McLaughlin; T Naessén; J F Fraumeni
Journal:  Cancer Causes Control       Date:  1994-11       Impact factor: 2.506

10.  Heterogeneity of mucin gene expression in normal and neoplastic tissues.

Authors:  S B Ho; G A Niehans; C Lyftogt; P S Yan; D L Cherwitz; E T Gum; R Dahiya; Y S Kim
Journal:  Cancer Res       Date:  1993-02-01       Impact factor: 12.701

View more
  65 in total

1.  PTEN expression in benign human endometrial tissue and cancer in relation to endometrial cancer risk factors.

Authors:  Hannah P Yang; Alan Meeker; Richard Guido; Marc J Gunter; Gloria S Huang; Patricia Luhn; Lori d'Ambrosio; Nicolas Wentzensen; Mark E Sherman
Journal:  Cancer Causes Control       Date:  2015-09-16       Impact factor: 2.506

2.  Prospective study of body size throughout the life-course and the incidence of endometrial cancer among premenopausal and postmenopausal women.

Authors:  Marcelle M Dougan; Susan E Hankinson; Immaculata De Vivo; Shelley S Tworoger; Robert J Glynn; Karin B Michels
Journal:  Int J Cancer       Date:  2015-02-05       Impact factor: 7.396

3.  Replication of genetic loci for ages at menarche and menopause in the multi-ethnic Population Architecture using Genomics and Epidemiology (PAGE) study.

Authors:  C L Carty; K L Spencer; V W Setiawan; L Fernandez-Rhodes; J Malinowski; S Buyske; A Young; N W Jorgensen; I Cheng; C S Carlson; K Brown-Gentry; R Goodloe; A Park; N I Parikh; B Henderson; L Le Marchand; J Wactawski-Wende; M Fornage; T C Matise; L A Hindorff; A M Arnold; C A Haiman; N Franceschini; U Peters; D C Crawford
Journal:  Hum Reprod       Date:  2013-03-18       Impact factor: 6.918

Review 4.  Epidemiology of Patients with Ovarian Cancer with and Without a BRCA1/2 Mutation.

Authors:  Elisabete Weiderpass; Jerzy E Tyczynski
Journal:  Mol Diagn Ther       Date:  2015-12       Impact factor: 4.074

5.  Is there a benefit of lymphadenectomy for overall and recurrence-free survival in type I FIGO IB G1-2 endometrial carcinoma? A retrospective population-based cohort analysis.

Authors:  Thomas Papathemelis; Dunja Hassas; Michael Gerken; Monika Klinkhammer-Schalke; Anton Scharl; Michael P Lux; Mathias W Beckmann; Sophia Scharl
Journal:  J Cancer Res Clin Oncol       Date:  2018-07-23       Impact factor: 4.553

6.  The occurrence of fetal microchimeric cells in endometrial tissues is a very common phenomenon in benign uterine disorders, and the lower prevalence of fetal microchimerism is associated with better uterine cancer prognoses.

Authors:  Ilona Hromadnikova; Katerina Kotlabova; Petra Pirkova; Pavla Libalova; Zdenka Vernerova; Bohuslav Svoboda; Eduard Kucera
Journal:  DNA Cell Biol       Date:  2013-11-27       Impact factor: 3.311

7.  Factors influencing ovulation and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers.

Authors:  Joanne Kotsopoulos; Jan Lubinski; Jacek Gronwald; Cezary Cybulski; Rochelle Demsky; Susan L Neuhausen; Charmaine Kim-Sing; Nadine Tung; Susan Friedman; Leigha Senter; Jeffrey Weitzel; Beth Karlan; Pal Moller; Ping Sun; Steven A Narod
Journal:  Int J Cancer       Date:  2014-12-18       Impact factor: 7.396

8.  Lifetime Number of Ovulatory Cycles and Risks of Ovarian and Endometrial Cancer Among Postmenopausal Women.

Authors:  Hannah P Yang; Kelsey R Murphy; Ruth M Pfeiffer; Neena George; Montserrat Garcia-Closas; Jolanta Lissowska; Louise A Brinton; Nicolas Wentzensen
Journal:  Am J Epidemiol       Date:  2016-04-15       Impact factor: 4.897

9.  Risk of Sex-Specific Cancers in Opposite-Sex and Same-Sex Twins in Denmark and Sweden.

Authors:  Linda J Ahrenfeldt; Axel Skytthe; Sören Möller; Kamila Czene; Hans-Olov Adami; Lorelei A Mucci; Jaakko Kaprio; Inge Petersen; Kaare Christensen; Rune Lindahl-Jacobsen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-08-17       Impact factor: 4.254

10.  Obesity Contributes to Ovarian Cancer Metastatic Success through Increased Lipogenesis, Enhanced Vascularity, and Decreased Infiltration of M1 Macrophages.

Authors:  Yueying Liu; Matthew N Metzinger; Kyle A Lewellen; Stephanie N Cripps; Kyle D Carey; Elizabeth I Harper; Zonggao Shi; Laura Tarwater; Annie Grisoli; Eric Lee; Ania Slusarz; Jing Yang; Elizabeth A Loughran; Kaitlyn Conley; Jeff J Johnson; Yuliya Klymenko; Lana Bruney; Zhong Liang; Norman J Dovichi; Bentley Cheatham; W Matthew Leevy; M Sharon Stack
Journal:  Cancer Res       Date:  2015-11-16       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.